Bachmeier E, Mazzeo MA, López
MM, Linares JA, Jarchum G, Wietz
FM, Finkelberg AB. Mucositis and salivary antioxidants in
patients undergoing bone marrow transplantation (BMT). Med Oral Patol Oral Cir Bucal. 2014 Sep 1;19
(5):e444-50.
doi:10.4317/medoral.19062
http://dx.doi.org/doi:10.4317/medoral.19062
|
1. Sonis ST. Mucositis as a
biological process: a new hypothesis for the development of
chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34:39-43. |
|
|
|
|
|
2. Sonis ST, Fey EG. Oral complications of cancer therapy. Oncology
(Williston Park). 2002;16:680-6. |
|
|
|
|
|
3. Robien K, Schubert MM, Bruemmer
B, Lloid ME, Potter JD, Ulrich CM. Predictors of
oral mucositis in patients receiving hematopoietic
cell transplants for chronic myelogenous leukemia. J Clin Oncol. 2004;22:1268-75. |
|
|
|
|
|
4. Barasch A, Peterson DE. Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol. 2003;39:91-100. |
|
|
|
|
|
5. Epstein
JB, Schubert MM. Oropharyngeal mucositis
in cancer therapy. Review of pathogenesis, diagnosis and management. Oncology (Williston
Park). 2003;17:1767-79. |
|
|
|
|
|
6. Knox
JJ, Puodziunas ALV, Feld
R. Chemotherapyinduced oral mucositis.
Prevention and management. Drugs
Aging. 2000;17:257-67. |
|
|
|
|
|
7. Blijlevens NMA, Donnelly JP, De Pauw
BE. Mucosal barrier injury: biology, pathology, clinical counterparts and
consequences of intensive treatment for haematological
malignancy: an overview. Bone Marrow Transplant.
2000;25:1269-78. |
|
|
|
|
|
8. Bellm LA, Epstein JB, Rose-Ped
A, Martin P, Fuchs HG. Patient reports of complications of bone marrow
transplantation. Support Care Cancer. 2000;8:33-9. |
|
|
|
|
|
9. Gabriel
DA, Shea T, Olajida O, Serody
JS, Comeau T. The effect of oral mucositis on morbidity and mortality in bone marrow
transplant. Semin Oncol. 2003;30(6 Suppl 18):76-83. |
|
|
|
|
|
10.
McCarthy GM, Awde JD, Ghandi
H, Vincent M, Kocha WI. Risk factors associated
with mucositis in cancer patients receiving
5-fluorouracil. Oral Oncol.
1998;34:484-90. |
|
|
|
|
|
11.
Rubenstein EB, Peterson DE, Shubert M, Keefe D, McGuire D, Epstein J, et al.
Clinical practice guidelines for the prevention and treatment of cancer
therapy-induced oral and gastrointestinal mucositis.
Cancer. 2004;100:2026-46. |
|
|
|
|
|
12. Sonis ST. Mucositis as a
biological process: a new hypothesis for the development of
chemotherapy-induced stomatotoxicity. Oral Oncol. 1998;34:39-43. |
|
|
|
|
|
13. Kohen R, Tirosh O, Kopolovich K. The reductive capacity index of saliva
obtained from donors of various ages. Exp Gerontol.
1992;27:161-8. |
|
|
|
|
|
14. Dajani AS, Veres CM, Law DJ.
Substances that interfere with action of viridian B, a Steptococcm,
us mitis bacteriocin. Infect Immun. 1978;20:20-4. |
|
|
|
|
|
15.
Yamamoto M, Saeki K, Utsumi K. Isolation of human
salivary polymorphonuclear leukocytes and their
stimulation-coupled responses. Arch Biochem
Biophys. 1991;289:76-82. |
|
|
|
|
|
16. Silness J, Löe H. Periodontal
disease in pregnancy. II. Correlation between oral hygiene and periodontal
condition. Acta Odontol Scand. 1964;22:121-35. |
|
|
|
|
|
17. Löe H, Silness J. Periodontal
disease in pregnancy I. Prevalence and severity. Acta Odontol Scand.
1963;21:533-51. |
|
|
|
|
|
18. Muhlemann HR, Son S. Gingival sulcus
bleeding-a leading symptom in initial gingivitis. Helv Odontol
Act. 1971;15:107-13. |
|
|
|
|
|
19. Coracin
FL, Santos PS, Gallottini MH, Saboya R, Musqueira PT, Barban A, et al. Oral health as a predictive factor for oral mucositis. Clinics (Sao Paulo). 2013;68:792-6. |
|
|
|
|
|
20. Hershkovich O, Nagler RM. Biochemicals Analysis of saliva and taste acuity
evaluation in patients with burning mouth syndrome, xerostomia
and / or gustatory disturbances. Arch Oral Biol.
2004;49:515-22. |
|
|
|
|
|
21. García Callejo FJ, Orts Alborch MH, Velert Vila MM, Martínez Beneyto MP. Variations
of salivary dismutase superoxide in tonsillar
infection. Acta Otorrinolaringol Esp. 2003;54:78-80. |
|
|
|
|
|
22. Nagler RM, Klein I, Zarzhevsky
N, Drigues N, Reznick
AZ. Characterization of the differentiated antioxidant profile of human
saliva. Free Radic Biol Med. 2002;32:268-77. |
|
|
|
|
|
23. Sang-Chul Kim, Ok-Su Kim, Ok-Joon
Kim, Young-Joon Kim, Hyun-Ju
Chung. Antioxidant profile of whole saliva after scaling and root planing in periodontal disease. J Periodontal Implant
Sci. 2010;40:164-71. |
|
|
|
|
|
24. Battino M, Bullon P, Wilson M,
Newman H. Oxidative injury and inflammatory periodontal diseases: the
challenge of anti-oxidants to free radicals and reactive oxygen species. Crit Rev Oral Biol Med. 1999;10:458-76. |
|
|
|
|
|
25.
Yamamoto M, Saeki K, Utsumi K. Isolation of human
salivary polymorphonuclear leukocytes and their
stimulation-coupled responses. Arch Biochem
Biophys. 1991;289:76-82. |
|
|
|
|
|
26. Chapple IL, Brock G, Eftimiadi
C, Matthews JB. Glutathione in gingival crevicular
fluid and its relation to local antioxidant capacity in periodontal health
and disease. Mol Pathol.
2002;55:367-73. |
|
|
|
|
|
27. Moore
S, Calder KA, Miller NJ, Rice-Evans CA. Antioxidant activity of saliva and
periodontal disease. Free Radic
Res. 1994;21:417-25. |
|
|
|
|
|
28. Akalin FA, Toklu E, Renda N. Analysis of superoxide dismutase activity levels
in gingiva and gingival crevicular
fluid in patients with chronic periodontitis and periodontally healthy controls. J Clin Peridontol.
2005;32:238-43. |
|
|
|
|
|
29. Ellis
SD, Tucci MA, Serio FG, Johnson RB. Factors for progression of
periodontal diseases. J Oral Pathol Med. 1998;27:101-5. |
|
|
|
|
|
30. Chapple ILC, Mason GI, Garner I,
Matthews JB, Thorpe GH, Maxwell SRJ, et al. Enhanced chemoluminiscent
assay for measuring total antioxidant capacity of serum, saliva and crevicular fluid. Ann Clin Biochem. 1997;34:412-21. |
|
|
|
|
|
31. Halliwell B. Free radicals, antioxidants, and human
disease: curiosity, cause, or consequence?. Lancet. 1994;344:721-4. |
|
|
|
|
|
32. Canakci CF, Cicek Y, Yildirim A, Sezer U, Canakci V. Increased levels of 8- hydroxydeoxyguanosine
and malondialdehyde and its relationship with the
antioxidant enzymes in saliva of periodontitis
patients. Eur J Dent. 2009;3:100-6. |
|
|
|
|
|
33. Wei D,
Zhang XL, Wang YZ, Yang CX, Chan G. Lipid peroxidation
levels, total antioxidant status and superoxide dismutase in serum, saliva
and gingival crevicular fluid in chronic periodontitis patients before and after periodontal
therapy. Aust Dent J. 2010;55:70-8. |
|
|
|
|
|
34. Goll RD, Mookerjee BK.
Correlation of biochemical parameters in serum and saliva in chronic azotemic patients and patients on chronic hemodialysis. J Dial.
1978;2:399-414. |
|
|
|
|
|
35. Bibi G, Green Y, Nagler RM.
Compositional and Oxidative Analysis in the Saliva and Serum of Predialysis Chronic Kidney Disease Patients and End-stage
Renal Failure Patients on Peritoneal Dialysis. Ther
Apher and Dial. 2008;12:164-70. |
|
|
|
|
|
36.
Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe
K, Katoh N, et al. Immunohistochemical
detection of advanced glycosylation end-products in
the peritoneum and its possible pathophysiological
role in CAPD. Kidney Int. 1997;51:182-6. |
|
|
|
|
|
37.
Nilsson-Thorell CB, Muscalu
N, Andrén AH, Kjellstrand
PT, Wieslander AP. Heat sterilization of fluids for
peritoneal dialysis gives rise to aldehydes. Perit Dial Int. 1993;13:208-13. |
|